You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Overall survival

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Meningioma, Meningioma Atypical, Anaplastic Meningioma Trial in Rome (Biological biomarker assessment)

Recruiting
  • Meningioma
  • +2 more
  • Biological biomarker assessment
  • Rome, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Mar 29, 2023

Survival in Adult MRD Positive Acute Lymphoblastic Leukemia

Completed
  • Acute Lymphoblastic Leukemia
    • Brno, Czechia
    • +9 more
    Sep 12, 2022

    Chromosomal Instability in Ovarian Cancer

    Recruiting
    • Epithelial Ovarian Cancer
    • +7 more
    • Testing for chromosomal instability (CIN)
    • Beijing, Beijing, China
      Lei Li
    Mar 26, 2022

    Waldenstrom's Disease, Prognostic Index Trial in France

    Not yet recruiting
    • Waldenstrom's Disease
    • Prognostic Index
      • Amiens, France
      • +14 more
      Jun 12, 2023

      Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation

      Completed
      • Stem Cell Transplantation
        • Princeton, New Jersey
          Local Institution
        Jun 13, 2022

        PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer

        Recruiting
        • Immune Checkpoint Inhibitors
        • +9 more
        • Radiotherapy for targeted lesions and PD-1 antibody
        • Beijing, Beijing, China
          Lei Li
        Apr 1, 2022

        NSCLC Trial (pembrolizumab, carboplatin, paclitaxel)

        Active, not recruiting
        Has Results
        • Non-small Cell Lung Cancer
        • pembrolizumab
        • +3 more
        • (no location specified)
        Aug 18, 2022

        Overall Survival and Effectiveness Predictors for mCRPCReal Life

        Completed
        • Prostatic Neoplasms, Castration-Resistant
        • Radium-223-dichloride (Xofigo, BAY88-8223)
        • Multiple Locations, Germany
          Many Locations
        Nov 1, 2021

        HRD and Resistance to PAPPi in EOC Patients

        Recruiting
        • Epithelial Ovarian Cancer
        • +6 more
        • Testing of homologous recombination deficiency
        • Beijing, Beijing, China
          Lei Li
        Mar 26, 2022

        Phase I Compare OS in Post-CyberKnife Radiosurgery Tx in 1-3 VS

        Withdrawn
        • Brain and Nervous System
          • (no location specified)
          Jan 20, 2022

          ALK-positive NSCLC in Sweden: Sequencing of ALK Tyrosine Kinase

          Completed
          Has Results
          • ALK-positive NSCLC
          • Sollentuna, Sweden
            Pfizer Innovations AB
          Mar 14, 2022

          NSCLC Trial (pembrolizumab, carboplatin, paclitaxel)

          Active, not recruiting
          Has Results
          • Non-small Cell Lung Cancer
          • pembrolizumab
          • +3 more
          • (no location specified)
          Aug 18, 2022

          Brain Tumor, Brain Tumors, Brain Cancer Trial in Milan, Palermo, Valladolid (Ultrasound)

          Recruiting
          • Brain Tumor
          • +4 more
          • Ultrasound
          • Milan, Italy
          • +2 more
          May 25, 2022

          Overall Survival Trial in Qingdao (Rituximab + zanubrutinib + lenalidomide)

          Recruiting
          • Overall Survival
          • Rituximab + zanubrutinib + lenalidomide
          • Qingdao, Shandong, China
            Qingdao central Hospital
          May 22, 2022

          PREDICT Version 2.2 of Indian Women With Operable Breast Cancer

          Active, not recruiting
          • Operable Breast Neoplasms
          • prediction of overall survival using Web based PREDICTV2.0 portal
          • Mumbai, Maharashtra, India
            Tata Memorial Hospital
          Apr 28, 2022

          Overall Survival Trial in Qingdao (Anlotinib, PD-1 inhibitor)

          Recruiting
          • Overall Survival
          • Anlotinib, PD-1 inhibitor
          • Qingdao, Shandong, China
          • +1 more
          Feb 23, 2022

          Ewing's Sarcoma Trial in United States (Vigil, Temozolomide, Irinotecan)

          Completed
          Has Results
          • Ewing's Sarcoma
          • Vigil
          • +4 more
          • Little Rock, Arkansas
          • +5 more
          Dec 20, 2022

          Overall Survival Comparison Between the 2 Arms Trial (Surgery followed with chemoradiation, Standard chemoradiation,

          Withdrawn
          • Overall Survival Comparison Between the 2 Arms
          • Surgery followed with chemoradiation
          • +2 more
          • (no location specified)
          Nov 10, 2021

          Prostate Cancer Trial in Denmark, Finland, Norway (radiation, other, drug)

          Recruiting
          • Prostate Cancer
          • Radiotherapy or surgery
          • +2 more
          • Copenhagen, Denmark
          • +10 more
          Dec 22, 2022

          Hepatocellular Carcinoma, Cirrhosis, Liver Failure Trial in New Orleans (Branch Chain Amino Acid, maltodextrin)

          Withdrawn
          • Hepatocellular Carcinoma
          • +2 more
          • Branch Chain Amino Acid
          • maltodextrin
          • New Orleans, Louisiana
            University Medical Center New Orleans
          Jan 13, 2022

          Progress Free Survival (PFS) and Overall Survival (OS) Trial in Guangzhou (Bevacizumab Injection, Nivolumab)

          Completed
          • Progress Free Survival (PFS) and Overall Survival (OS)
          • Guangzhou, Guangdong, China
            Fuda Cnacer Hospital
          Sep 1, 2021

          Lung Cancer, Surgery, Blood Pressure Management Trial in Beijing (Dexamethasone, Targeted blood pressure management, Placebo)

          Recruiting
          • Lung Cancer
          • +5 more
          • Beijing, Beijing, China
            Department of Anesthesiology and Critical Care Medicine, Peking
          Aug 8, 2022

          Pancreatic Cancer Trial in Stockholm (Mistletoe extract (Iscador Qu), Placebo)

          Active, not recruiting
          • Pancreatic Cancer
          • Mistletoe extract (Iscador Qu)
          • Placebo
          • Stockholm, Sweden
            Kathrin Wode
          Mar 14, 2022

          Metastatic Breast Cancer Starting a Third Line Chemo Trial in France (Construction of a prognostic score (non-drug intervention

          Active, not recruiting
          • Metastatic Breast Cancer Starting a Third Line Chemotherapy
          • Construction of a prognostic score (non-drug intervention types)
          • Albi, France
          • +15 more
          Oct 15, 2021

          Pancreas Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Seoul (Measurement of triceps skinfold thickness)

          Recruiting
          • Pancreas Cancer
          • +2 more
          • Measurement of triceps skinfold thickness
          • Seoul, Korea, Republic of
            Samsung Medical Center
          Jan 24, 2021